Company intelligence / Profile preview

Medios AG

Ownership: Public · ILM1
Employees: ~952
Development stage: Commercial

Overview

Medios is the leading provider of Specialty Pharma in Germany with approximately €1.8 billion in revenue in 2023. The company operates 6 GMP facilities, 4 distribution sites, and a blistering center, making it the largest pharmaceutical supplier and compounder of patient-specific therapies in Germany.

Therapeutic areas: OncologyImmunologyHematologyOphthalmologyNeurologyInfectious Diseases
Modalities: Patient-specific therapiesCytostatic infusion preparationsAntibody therapiesVirostatic medicationsAntibiotic medicationsParenteral nutrition solutionsInvestigational medicinal products
Industry: Contract Manufacturing Organization

Partnerships

700+ medical specialists850+ pharmaciesPharmaceutical companies

Financials

Market cap: $143.5M
Total revenue: $0
Enterprise value: $20.7M

Beyond the preview

Go deeper on Medios AG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medios AG.

Explore the full profile